Citigroup reaffirmed a neutral rating on Sanofi stock.
1 report, 1 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reaffirmed a neutral rating on Sanofi stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sanofi
French pharmaceutical company
-
Citigroup
American investment bank and financial services corporation
Related events
- Citigroup reiterated a neutral rating on Norfolk Southern stock, while JPMorgan Chase & Co. issued a price target report.
- Citigroup reiterated a market outperform rating for Capital Southwest Corporation.
- Citigroup reissued a buy rating on Bankinter.
- Citigroup raised Amplifon shares to a buy rating.
- Citigroup upgraded its target price and gave a buy rating for Fortrea.